Pharmaceutical Product Monograph: Gentamicin Sulfate Injection (80 mg / 2 mL)
In the pharmaceutical industry, Gentamicin is a potent, water-soluble Aminoglycoside antibiotic derived from Micromonospora purpurea. As a pharmacist and manufacturer, I view this molecule as a “Concentration-Dependent Bactericidal”—it is technically designed to provide a rapid “kill-hit” against aerobic Gram-negative bacilli, including the highly resistant Pseudomonas aeruginosa.
At your WHO-GMP facility in Mumbai, the 80 mg / 2 mL strength is the international standard adult dose. It is a critical SKU for Emergency, Surgical, and Intensive Care portfolios worldwide.
Therapeutic Profile: Primary Indications
Gentamicin 80 mg is indicated for severe systemic infections where less toxic antibiotics are ineffective or contraindicated.
| Indication | Clinical Context | Technical Rationale |
| Septicemia | Bloodstream Infection | Used as an empirical “first-strike” drug for Gram-negative sepsis and neonatal sepsis. |
| Complicated UTI | Pyelonephritis | Gold Standard: Reaches very high concentrations in the renal cortex and urine. |
| Intra-abdominal | Peritonitis | Often combined with Metronidazole or Clindamycin to cover both aerobes and anaerobes. |
| Infective Endocarditis | Cardiac Infection | Used for its Synergistic Effect when combined with Penicillins or Vancomycin to kill Streptococci. |
| Pelvic Infections | PID / Endometritis | A core component of the “Triple Antibiotic” regimen used in severe gynecological infections. |
Mechanism: 30S Ribosomal Misreading
Gentamicin works by physically sabotaging the bacterial protein “factory”:
Active Transport: The drug is actively transported across the bacterial cell membrane via an oxygen-dependent process (which is why it doesn’t work on anaerobes).
Ribosomal Binding: It binds irreversibly to the 30S subunit of the bacterial ribosome.
Genetic Misreading: It causes the bacteria to “misread” its mRNA code, leading to the production of non-functional, toxic proteins.
Membrane Damage: These abnormal proteins insert themselves into the cell membrane, causing it to leak and resulting in rapid bacterial death.
The Pharmacist’s “Technical Warning”
The “Oto-Nephro” Toxicity: As a pharmacist, I must emphasize that Gentamicin is Ototoxic (hearing/balance loss) and Nephrotoxic (kidney damage). Both are often irreversible if not caught early.
Peak & Trough Monitoring: Technically, for a multi-dose 80 mg regimen, blood levels must be measured.
Trough Level: Should be $< 2 \text{ mcg/mL}$ before the next dose to ensure the kidneys are clearing the drug.
The “Once-Daily” Trend: Many hospitals now use “Extended Interval Dosing” (e.g., a single 5 mg/kg dose) instead of 80 mg every 8 hours. This is technically safer for the kidneys while maintaining the “Post-Antibiotic Effect” (PAE).
Neuromuscular Blockade: It can technically aggravate muscle weakness in patients with Myasthenia Gravis.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Stable Liquid” USP: Gentamicin Sulfate is highly heat-stable. On your digital marketplace, highlight your Terminally Sterilized 2 mL ampoules. This ensures a robust 36-month shelf life without refrigeration, making it a “Top-Tier” export SKU for Middle Eastern and African markets.
The “Combination Kit” Advantage: Market your Gentamicin 80 mg alongside Ampicillin or Cloxacillin. These “Synergy Packs” are high-demand items for B2B procurement by international NGOs and rural health clinics.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Gentamicin 40 mg/mL (2 mL) to support your registration in international B2B tenders for hospital supplies.